p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell.
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell.
复制标题
p21WAF1/CIP1基因转录激活可抑制肺癌细胞的生长并增强对顺铂的化疗敏感性。
DOI:
10.1186/1471-2407-10-632
复制
发表时间:
2010-11-19
期刊:
影响因子:
3.8
通讯作者:
Zhang H
中科院分区:
文献类型:
--
作者:
Wei J;Zhao J;Long M;Han Y;Wang X;Lin F;Ren J;He T;Zhang H
Non-small-cell lung carcinomas (NSCLCs) exhibit poor prognosis and are usually resistant to conventional chemotherapy. Absence of p21WAF1/CIP1, a cyclin-dependent kinase (cdk) inhibitor, has been linked to drug resistance in many in vitro cellular models. RNA activation (RNAa) is a transcriptional activation phenomena guided by double-strand RNA (dsRNA) targeting promoter region of target gene. In this study, we explored the effect of up-regulation of p21 gene expression on drug-resistance in A549 non-small-cell lung carcinoma cells by transfecting the dsRNA targeting the promoter region of p21 into A549 cells. Enhanced p21 expression was observed in A549 cells after transfection of dsRNA, which was correlated with a significant growth inhibition and enhancement of chemosensitivity to cisplatin in A549 cells in vitro. Moreover, in vivo experiment showed that saRNA targeting the promoter region of p21 could significantly inhibit A549 xenograft tumor growth. These results indicate that p21 plays a role in lung cancer drug-resistance process. In addition, this study also provides evidence for the usage of saRNA as a therapeutic option for up-regulating lower-expression genes in lung cancer.
登录
查看更多内容
影响因子:
64.8
作者:
Waldman, T;Lengauer, C;Vogelstein, B
通讯作者:
Vogelstein, B
影响因子:
8
作者:
Medema, RH;Klompmaker, R;Rijksen, G
通讯作者:
Rijksen, G
影响因子:
5.3
作者:
Niculescu, AB;Chen, XB;Reed, SI
通讯作者:
Reed, SI
影响因子:
5.3
作者:
Ogryzko, VV;Wong, P;Howard, BH
通讯作者:
Howard, BH
影响因子:
9.7
作者:
Yang, Kai;Zheng, Xiang-Yi;Xie, Li-Ping
通讯作者:
Xie, Li-Ping